)

COMPASS Pathways (CMPS) investor relations material
COMPASS Pathways Canaccord Genuity’s 45th Annual Growth Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Regulatory and industry landscape
Political and regulatory support for psychedelic treatments is seen as a tailwind, with leadership at HHS, FDA, and VA expressing urgency to address unmet mental health needs, especially in treatment-resistant depression and PTSD.
FDA remains engaged and responsive, with ongoing dialogue and breakthrough therapy designation facilitating frequent interactions.
The company has applied for the commissioner's priority voucher and scheduled a Type B meeting with the FDA this quarter to discuss data and potential accelerated filing scenarios.
No significant changes in the FDA team composition; engagement and support remain strong.
Clinical trial progress and data insights
Phase 2b study in treatment-resistant depression showed robust, statistically significant results at both three and six weeks, with a 25mg dose outperforming an active comparator.
Recent top-line data from the first phase 3 trial (COM005) demonstrated a clinically meaningful and statistically significant separation from placebo at week six after a single administration.
The DSMB issued a clean safety statement for patients in both phase 3 trials, with no new safety signals or imbalances.
The upcoming 26-week dataset from part B of the phase 3 trial will provide comprehensive efficacy and safety data, including durability and retreatment effects.
Market positioning and commercialization
Major biopharma interest in the psychedelic space is growing, with ongoing conversations and validation from recent industry activity.
Confident in ability to commercialize in the US due to unique skill sets and experience; may seek partners for ex-US markets.
Less frequent administration compared to SPRAVATO could reduce patient and caregiver burden and potentially demonstrate greater value.
Interventional psychiatry infrastructure has scaled, with over 6,000 sites delivering SPRAVATO, supporting future commercial scale.
Next COMPASS Pathways earnings date

Next COMPASS Pathways earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage